Olive oil phenolic compounds and high-density lipoprotein function

Current Opinion in Lipidology

Volumn 27, Issue 1, 2016, Pages 47-53

  Hernáez, Alvaro ^a,b,c   Farràs, Marta ^a,b   Fitó, Montserrat ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

cholesterol efflux capacity; high density lipoprotein antioxidant capacity; high density lipoprotein function; olive oil phenolic compounds

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; PHENOL DERIVATIVE;

ANIMAL; HUMAN; METABOLISM;

ANIMALS; CHOLESTEROL, HDL; HUMANS; OLIVE OIL; PHENOLS;

EID: 84954367892     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000261     Document Type: Review

References (50)

1. Castelli WP, Doyle JT, Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977; 55: 767-772.
2. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012; 380: 572-580.
3. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007; 357: 2109-2122.
4. Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev. 2006; 58: 342-374.
5. Rohatgi A, Khera A, Berry JD, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014; 371: 2383-2393.
6. Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011; 364: 127-135.
7. Besler C, Lüscher TF, Landmesser U. Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease. EMBO Mol Med. 2012; 4: 251-268.
8. Guasch-FerréM, Hu FB, Martínez-González MA, et al. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014; 12: 78.
9. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003; 348: 2599-2608.
10. Estruch R, Ros E, Salas-SalvadóJ, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013; 368: 1279-1290.
11. De Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999; 99: 779-785.
12. Covas MI, Nyyssönen K, Poulsen HE, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med. 2006; 145: 333-341.
13. Lou-Bonafonte JM, FitóM, Covas M-I, et al. HDL-related mechanisms of olive oil protection in cardiovascular disease. Curr Vasc Pharmacol. 2012; 10: 392-409.
14. Zhu Y, Huang X, Zhang Y, et al. Anthocyanin supplementation improves HDLassociated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia. J Clin Endocrinol Metab. 2014; 99: 561-569.
15. Hernáez Á, Fernández-Castillejo S, Farràs M, et al. Olive oil polyphenols enhance high-density lipoprotein function in humans: a randomized controlled trial. Arterioscler Thromb Vasc Biol. 2014; 34: 2115-2119.
16. Atzeri A, Lucas R, Incani A, et al. Hydroxytyrosol and tyrosol sulfate metabolites protect against the oxidized cholesterol pro-oxidant effect in Caco-2 human enterocyte-like cells. Food Funct 2015. [In press
17. Cherki M, Derouiche A, Drissi A, et al. Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. Nutr Metab Cardiovasc Dis. 2005; 15: 352-360.
18. Loued S, Berrougui H, Componova P, et al. Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities. Br J Nutr. 2013; 110: 1272-1284.
19. Bonnefont-Rousselot D, Motta C, Khalil AO, et al. Physicochemical changes in human high-density lipoproteins (HDL) oxidized by gamma radiolysisgenerated oxyradicals. Effect on their cholesterol effluxing capacity. Biochim Biophys Acta. 1995; 1255: 23-30.
20. Helal O, Berrougui H, Loued S, Khalil A. Extra-virgin olive oil consumption improves the capacity of HDL to mediate cholesterol efflux and increases ABCA1 and ABCG1 expression in human macrophages. Br J Nutr. 2013; 109: 1844-1855.
21. Sparks DL, Davidson WS, Lund-Katz S, Phillips MC. Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J Biol Chem. 1995; 270: 26910-26917.
22. Farrà s M, Castañer O, Martín-Peláez S, et al. Complementary phenol-enriched olive oil improves HDL characteristics in hypercholesterolemic subjects A randomised, double-blind, crossover, controlled trial. The VOHF study. Mol Nutr Food Res. 2015; 59: 1758-1770.
23. RubióL, Motilva MJ, Macià A, et al. Development of a phenol-enriched olive oil with both its own phenolic compounds and complementary phenols from thyme. J Agric Food Chem. 2012; 60: 3105-3112.
24. Pedret A, Catalán Ú, Fernández-Castillejo S, et al. Impact of virgin olive oil and phenol-enriched virgin olive oils on the hdl proteome in hypercholesterolemic subjects: a double blind, randomized, controlled, cross-over clinical trial (VOHF Study). PLoS One. 2015; 10: e0129160.
25. Farrà s M, Valls RM, Fernández-Castillejo S, et al. Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans A randomized controlled trial. J Nutr Biochem. 2013; 24: 1334-1339.
26. Hamblin M, Chang L, Fan Y, et al. PPARs and the cardiovascular system. Antioxid Redox Signal. 2009; 11: 1415-1452.
27. Konstantinidou V, Khymenets O, Covas MI, et al. Time course of changes in the expression of insulin sensitivity-related genes after an acute load of virgin olive oil. OMICS. 2009; 13: 431-438.
28. Konstantinidou V, Covas MI, Muñoz-Aguayo D, et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB J. 2010; 24: 2546-2557.
29. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340: 115-126.
30. Soran H, Schofield JD, Liu Y, Durrington PN. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae. Curr Opin Lipidol. 2015; 26: 247-256.
31. Arbonés-Mainar JM, Navarro MA, Carnicer R, et al. Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: a role for small, dense high-density lipoproteins. Atherosclerosis. 2007; 194: 372-382.
32. Rosenblat M, Volkova N, Coleman R, et al. Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux. J Nutr Biochem. 2008; 19: 514-523.
33. Bayram B, Ozcelik B, Grimm S, et al A diet rich in olive oil phenolics reduces oxidative stress in the heart of SAMP8 mice by induction of Nrf2-dependent gene expression. Rejuvenation Res. 2012; 15: 71-81.
34. Valls RM, Farràs M, Suárez M, et al. Effects of functional olive oil enriched with its own phenolic compounds on endothelial function in hypertensive patients A randomised controlled trial. Food Chem. 2015; 167: 30-35.
35. Moreno-Luna R, Muñoz-Hernandez R, Miranda ML, et al. Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am J Hypertens. 2012; 25: 1299-1304.
36. Schwingshackl L, Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-Analysis of intervention trials. Nutr Metab Cardiovasc Dis. 2014; 24: 929-939.
37. Meza-Miranda ER, Rangel-Zúñiga OA, Marín C, et al. Virgin olive oil rich in phenolic compounds modulates the expression of atherosclerosis-related genes in vascular endothelium. Eur J Nutr 2015. [In press
38. Richard C, Couture P, Desroches S, et al. Effect of an isoenergetic traditional Mediterranean diet on the high-density lipoprotein proteome in men with the metabolic syndrome. J Nutrigenet Nutrigenomics. 2014; 7: 48-60.
39. Otvos JD, Collins D, Freedman DS, et al. Low-density lipoprotein and highdensity lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation. 2006; 113: 1556-1563.
40. Damasceno NRT, Sala-Vila A, Cofán M, et al. Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk. Atherosclerosis. 2013; 230: 347-353.
41. López-Miranda J, Gómez P, Castro P, et al. Mediterranean diet improves low density lipoprotein susceptibility to oxidative modifications. Med Clin (Barc) 2000; 115: 361-365.
42. Derouiche A, Cherki M, Drissi A, et al. Nutritional intervention study with argan oil in man: effects on lipids and apolipoproteins. Ann Nutr Metab. 2005; 49: 196-201.
43. Martínez-Beamonte R, Navarro MA, Acin S, et al. Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oil. PLoS One. 2013; 8: e55231.
44. Richard C, Couture P, Desroches S, et al. Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome. Nutr J. 2013; 12: 76.
45. Pirillo A, Norata GD, Catapano AL. High-density lipoprotein subfractions: what the clinicians need to know. Cardiology. 2013; 124: 116-125.
46. Jones JL, Comperatore M, Barona J, et al A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome. Metabolism. 2012; 61: 366-372.
47. Mangas-Cruz MA, Fernández-Moyano A, Albi T, et al. Effects of minor constituents (nonglyceride compounds) of virgin olive oil on plasma lipid concentrations in male Wistar rats. Clin Nutr. 2001; 20: 211-215.
48. De la Llera-Moya M, Drazul-Schrader D, Asztalos BF, et al. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol. 2010; 30: 796-801.
49. Sankaranarayanan S, Oram JF, Asztalos BF, et al. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J Lipid Res. 2009; 50: 275-284.
50. Alwaili K, Bailey D, Awan Z, et al. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim Biophys Acta. 2012; 1821: 405-415.